මධ්යස්ථානය සම්බන්ධ කර ගන්නේ කෙසේද
HCP මධ්යස්ථානය

සේවකයින් 14.100ක් පමණ සිටින, UKE Hamburg හි Free and Hanseatic City හි තුන්වන විශාලතම සේවා යෝජකයා වේ.
UKE හි පර්යේෂණ
රෝග විනිශ්චය සහ චිකිත්සාවෙහි ප්රගතිය සඳහා පර්යේෂණ වැදගත් පූර්ව අවශ්යතාවයකි. UKE හි පර්යේෂණවල අවධාරණය වන්නේ ස්නායු විද්යාව, හෘද-සනාල පර්යේෂණ, සත්කාර පර්යේෂණ, ඔන්කොලොජි, මෙන්ම ආසාදන සහ දැවිල්ලයි. UKE හි අනෙකුත් විභව ක්ෂේත්ර වන්නේ අණුක රූප සහ අස්ථි ජීව විද්යා පර්යේෂණ වේ.
අමතන්න
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
කණ්ඩායම

Pr Martin Spitzer
ජර්මනිය

Dr Johannes Birtel
ජර්මනිය
සායනික පරීක්ෂණ

A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

European Disease Registry on Retinopathy of Prematurity (ROP)

Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion

A Phase III, Multicentre, International Study With a Parallel, Randomised, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET)

An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema Conditions

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma (DecodeVRL)

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER)